Z-1497-2026 Class II Ongoing

Recalled by Ion Beam Applications S.A. — Ottignies-Louvain-La-Neuve, N/A

FDA device recall Z-1497-2026 was initiated by Ion Beam Applications S.A. on February 3, 2026 and is designated Class II. Reason for recall: It was identified that eh Universal Beam Triggering Interface (UBTI) is disabled in the Therapy Safety System (TSS) configuration. In this condition, the TSS does not interrupt the beam delivery if th… The recall status is ongoing. Affected quantity: 4 units (1 US, 3 OUS).

Recall Details

Product Type
Devices
Report Date
March 18, 2026
Initiation Date
February 3, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4 units (1 US, 3 OUS)

Product Description

IBA Proton Therapy System - PROTEUS 235

Reason for Recall

It was identified that eh Universal Beam Triggering Interface (UBTI) is disabled in the Therapy Safety System (TSS) configuration. In this condition, the TSS does not interrupt the beam delivery if the Healthy Signal from an external gating device is lost. This may lead to a risk of mistreatment when external gating devices are used.

Distribution Pattern

Worldwide - US Nationwide distribution in the state of FL and the countries of Italy and Japan.

Code Information

PROTEUS 235; UDI-DI: 05404013801138; Serial Numbers: SBF103 (JP), SBF124 (EU), SBF133 (US), SBF140 (EU)